Status: Recruiting
Implantable Microdevice In Primary Brain Tumors
This pilot study will assess the safety and feasibility of using an implantable microdevice to measure local intratumor response to chemotherapy and other clinically relevant drugs in malignant brain tumors. * The device involved in this study is called a microdevice. * The drugs used in this study will only include drugs already used systemically for the treatment of gliomas.
Participants needed: 12
Trial details
Phase: Early Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Oliver JonasUpdated: Jul 23, 2025Locations: 1
Eligibility criteria
Patients must have operable supratentorial tumor presumed to be WHO grade II-IV... [+14]
Participants who have had chemotherapy or radiotherapy within 4 weeks (6 weeks f... [+8]